CF
LNAI

Cantor Fitzgerald’s Lunai Bioworks LNAI Stock Holding History

Cantor Fitzgerald’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,750
Closed -$251K – 381
2024
Q4 		$251K Buy
3,750
+2,500
+200% +$166K 0.01% 164
2024
Q3 		$48.3K Buy
+1,250
New +$86.7K ﹤0.01% 166
2023
Q1 		– Sell
-747
Closed -$62K – 723
2022
Q4 		$62K Buy
747
+173
+30% +$23.2K ﹤0.01% 618
2022
Q3 		$83K Hold
574
– – ﹤0.01% 636
2022
Q2 		$89K Buy
574
+105
+22% +$48K ﹤0.01% 687
2022
Q1 		$309K Buy
+469
New +$250K 0.02% 236

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cantor Fitzgerald's LNAI Position: Q1 2025 in Review

Cantor Fitzgerald sold out of Lunai Bioworks (LNAI) in Q1 2025, closing a stake of 3,750 shares — an estimated $251K sold.

Cantor Fitzgerald first reported a position in LNAI in Q1 2022 and held it in 6 quarters. The position peaked at $309K in Q1 2022. 60 funds tracked by Wall St. Rank hold LNAI as of Q1 2025.

  • Cantor Fitzgerald reported no remaining Lunai Bioworks position as of Q1 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 3,750 Lunai Bioworks shares in Q1 2025, an estimated $251K.
  • Cantor Fitzgerald first reported a position in Lunai Bioworks in Q1 2022 and held it in 6 quarters.
  • Cantor Fitzgerald's Lunai Bioworks position peaked at $309K in Q1 2022.
  • 60 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.